Abstract:The convenient and precise fabrication of drug-hydrogel formulations with satisfactory degradability and a well-controlled drug release profile are crucial factors for injectable hydrogel formulations in clinical applications. Here a new injectable thermosensitive hydrogel formed from poly(ε-caprolactone) (PCL)-poly(ethylene glycol)-poly(ε-caprolactone) amphiphilicco-polymers with 1,4,8-trioxa[4.6]spiro-9-undecanone (TOSUO) moieties incorporated in the poly(ε-caprolactone) (PCL)block (PECT) was constructed to provide a route to tailor the degradation and drug release behavior. The effect of hydrophilic cyclic ether moieties on the degradation of and drug release by PECT hydrogels were evaluated in vitro and in vivo. The results indicated that a freeze-dried powder of paclitaxel-loaded PECT nanoparticles rapidly dissolved in water at ambient temperature with slightly shaking and formed a stable injectable in situ drug-hydrogel formulation at body temperature, which is convenient for clinical operations because it avoids the need for pre-quenching or long-term incubation. The paclitaxel distribution was also more quantitative and homogeneous on entrapping paclitaxel in PECT nanoparticles. Further, the small number of pendant cyclic ether groups in PCL could decrease the cystallinity and hydrophobicity and, as a result, the in vitro and in vivo retention time of PECT hydrogels and the release of entrapped paclitaxel could be tuned from a few weeks to months by varying the amount of PTOSUO in the hydrophobic block. Significantly, paclitaxel-loaded PECT nanoparticles and free paclitaxel could be simultaneously released during the in vitro paclitaxel release from PECT hydrogels. A histopathological evaluation indicated that in vivo injected PECT hydrogels produced only a modest inflammatory response. Thus pendant cyclic ether modification of PCL could be an effective way to achieve the desired degradation and drug release profiles of amphiphilicco-polymer thermosensitive hydrogels and PECT hydrogels may be suitable for local drug delivery.

Cucurbit[7]-assisted Sustained Release of Human Calcitonin from Thermosensitive Block Copolymer Hydrogel.

Novel Complex Hydrogels Based on N-carboxyethyl Chitosan and Quaternized Chitosan and Their Controlled in Vitro Protein Release Property.

Adjustable Degradation and Drug Release of a Thermosensitive Hydrogel Based on a Pendant Cyclic Ether Modified Poly(ε-Caprolactone) and Poly(ethylene Glycol)co-Polymer

Thermosensitive Hydrogel Based on Poly(2-Ethyl-2-Oxazoline)–Poly(D,L-Lactide)–Poly(2-Ethyl-2-Oxazoline) for Sustained Salmon Calcitonin Delivery

Calcitonin-Loaded Thermosensitive Hydrogel for Long-Term Antiosteopenia Therapy.

Thermo-Sensitive mPEG-PA-PLL Hydrogel for Drug Release of Calcitonin

Sulfated alginate based complex for sustained calcitonin delivery and enhanced osteogenesis

Sustained Release of Doxorubicin from a Thermosensitive Hydrogel

Encapsulation and sustained release of curcumin by hawthorn pectin and Tenebrio Molitor protein composite hydrogel

Transdermal Delivery of Salmon Calcitonin Using a Dissolving Microneedle Array: Characterization, Stability, and In vivo Pharmacodynamics

Injectable Block Copolymer Hydrogels for Sustained Release of a PEGylated Drug

Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles

Thermogelling Implant Drug Delivery System with Poly-3-hydroxybutyrate Based on Microparticles

Sustained drug release from an ultrathin hydrogel film

Guar-Based Injectable Thermoresponsive Hydrogel as a Scaffold for Bone Cell Growth and Controlled Drug Delivery

An injectable thermo-sensitive hydrogel of PNICL-PEG-PNICL block copolymer as a sustained release carrier of EGCG

Temperature- and pH-responsive injectable chitosan hydrogels loaded with doxorubicin and curcumin as long-lasting release platforms for the treatment of solid tumors

Encapsulation of 10-Hydroxy Camptothecin in Supramolecular Hydrogel As an Injectable Drug Delivery System

Enhancement of Oral Bioavailability of Salmon Calcitonin Through Chitosan-Modified, Dual Drug-Loaded Nanoparticles.

A Facile Method to Prepare the Novel Biological HKUST-1@CMCS with Macroscopic-Shape Control for the Long-Acting and Sustained Release.

Tunable Thermo-Responsive Supramolecular Hydrogel: Design, Characterization, and Drug Release